// App-Quantinova.ai

14465 : Obesity Paradox on Outcome in Atrial Fibrillation Maintained Even Considering the Prognostic Influence of Biomarkers: Insights From the ARISTOTLE Trial

Researchers

Presenter

  • Roopinder K Sandhu

Principal Investigators

  • Justin Ezekowitz

  • Ziad Hijazi

  • Johan Westerbergh

  • John H Alexander

  • Christopher B Granger

  • Sigrun Halvorsen

  • Michael S Hanna

  • Renato D Lopes

  • Lars Wallentin

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • B-type natriuretic peptide

  • C reactive protein

  • Growth differentiation factor 15

  • High sensitivity C-reactive protein

  • Interleukin 6

  • Body mass index

  • N-terminal pro b-type natriuretic peptide

Drug/Treatment

  • Interleukin

  • apixaban

  • Warfarin

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved